Emily Kean-Puccioni, MD
Payments from drug & device makers
Across 317 payments — averaging $1173.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bluewind Medical$241K
- AbbVie$118K
- Cytyc Surgical Products, LLC$10K
- Valencia Technologies Corporation$947
- Sumitomo Pharma America, Inc.$653
- Medtronic$438
- plus $2K from 25 others
Across 1 payment — averaging $156.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bluewind Medical$157
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bluewind Medical | 102 | $240,899 |
| AbbVie(2 entities) | 61 | $117,610 |
| Cytyc Surgical Products, LLC | 4 | $9,600 |
| Valencia Technologies Corporation | 6 | $947 |
| Sumitomo Pharma America, Inc. | 31 | $653 |
| Medtronic(2 entities) | 20 | $438 |
| Astellas Pharma US Inc | 21 | $395 |
| Axonics, Inc. | 11 | $341 |
| Myovant Sciences Inc. | 9 | $155 |
| Boston Scientific | 6 | $141 |
| Dendreon Pharmaceuticals LLC | 6 | $115 |
| Bayer | 5 | $85 |
| Pfizer | 6 | $74 |
| Urovant Sciences Inc | 5 | $69 |
| Dornier Medtech America, Inc | 1 | $62 |
| Caldera Medical, Inc | 2 | $51 |
| Duchesnay USA Incorporated | 3 | $46 |
| Myriad Genetic Laboratories, Inc. | 3 | $38 |
| Urogen Pharma, Inc. | 2 | $36 |
| AstraZeneca | 2 | $27 |
| KARL Storz Endoscopy-america | 1 | $23 |
| Tolmar, Inc. | 1 | $22 |
| Accord Healthcare, Inc. | 1 | $21 |
| Merck | 1 | $19 |
| Coloplast | 1 | $18 |
| Foundation Medicine, Inc. | 1 | $16 |
| 180 Medical, Inc. | 1 | $15 |
| Clinigen, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Siemens Medical Solutions USA, Inc. | 1 | $13 |
| Amgen | 1 | $11 |
How this compares
$371,969 in reported general payments places this provider in the 90th percentile of 79 urology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Omaha
- John BishayOmaha$3.5M
- Judson DaviesOmaha$1.2M
- Andrew TrainerOmaha$852K
- Rebecca McCreryOmaha$624K
- Sida NiuOmaha$85K
- Michael FeloneyOmaha$69K
- Stefanie BolteOmaha$59K
- Euclid DesouzaOmaha$35K
- Brett HillOmaha$22K
- Jennifer DwyerOmaha$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.